200 related articles for article (PubMed ID: 17690249)
1. Mechanism of and requirement for estrogen-regulated MYB expression in estrogen-receptor-positive breast cancer cells.
Drabsch Y; Hugo H; Zhang R; Dowhan DH; Miao YR; Gewirtz AM; Barry SC; Ramsay RG; Gonda TJ
Proc Natl Acad Sci U S A; 2007 Aug; 104(34):13762-7. PubMed ID: 17690249
[TBL] [Abstract][Full Text] [Related]
2. Posttranscriptional regulation of the c-myb proto-oncogene in estrogen receptor-positive breast cancer cells.
Gudas JM; Klein RC; Oka M; Cowan KH
Clin Cancer Res; 1995 Feb; 1(2):235-43. PubMed ID: 9815978
[TBL] [Abstract][Full Text] [Related]
3. CDK9 inhibitors selectively target estrogen receptor-positive breast cancer cells through combined inhibition of MYB and MCL-1 expression.
Mitra P; Yang RM; Sutton J; Ramsay RG; Gonda TJ
Oncotarget; 2016 Feb; 7(8):9069-83. PubMed ID: 26812885
[TBL] [Abstract][Full Text] [Related]
4. Identification and regulation of c-Myb target genes in MCF-7 cells.
Quintana AM; Liu F; O'Rourke JP; Ness SA
BMC Cancer; 2011 Jan; 11():30. PubMed ID: 21261996
[TBL] [Abstract][Full Text] [Related]
5. [The expression of c-myb is strongly associated with the presence of estrogen and progesterone receptors in breast cancer].
Guerin M; Barrois M; Riou G
C R Acad Sci III; 1988; 307(20):855-61. PubMed ID: 2907731
[TBL] [Abstract][Full Text] [Related]
6. Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines.
Pink JJ; Jordan VC
Cancer Res; 1996 May; 56(10):2321-30. PubMed ID: 8625307
[TBL] [Abstract][Full Text] [Related]
7. Sulindac sulfide and exisulind inhibit expression of the estrogen and progesterone receptors in human breast cancer cells.
Lim JT; Joe AK; Suzui M; Shimizu M; Masuda M; Weinstein IB
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3478-84. PubMed ID: 16740773
[TBL] [Abstract][Full Text] [Related]
8. Estrogen-regulated gene networks in human breast cancer cells: involvement of E2F1 in the regulation of cell proliferation.
Stender JD; Frasor J; Komm B; Chang KC; Kraus WL; Katzenellenbogen BS
Mol Endocrinol; 2007 Sep; 21(9):2112-23. PubMed ID: 17550982
[TBL] [Abstract][Full Text] [Related]
9. Estrogen and MYB in breast cancer: potential for new therapies.
Gonda TJ; Leo P; Ramsay RG
Expert Opin Biol Ther; 2008 Jun; 8(6):713-7. PubMed ID: 18476782
[TBL] [Abstract][Full Text] [Related]
10. TGFβ-induced c-Myb affects the expression of EMT-associated genes and promotes invasion of ER+ breast cancer cells.
Cesi V; Casciati A; Sesti F; Tanno B; Calabretta B; Raschellà G
Cell Cycle; 2011 Dec; 10(23):4149-61. PubMed ID: 22101269
[TBL] [Abstract][Full Text] [Related]
11. P2Y2 receptor-mediated modulation of estrogen-induced proliferation of breast cancer cells.
Li HJ; Wang LY; Qu HN; Yu LH; Burnstock G; Ni X; Xu M; Ma B
Mol Cell Endocrinol; 2011 May; 338(1-2):28-37. PubMed ID: 21356271
[TBL] [Abstract][Full Text] [Related]
12. Estrogen receptor-α recruits P-TEFb to overcome transcriptional pausing in intron 1 of the MYB gene.
Mitra P; Pereira LA; Drabsch Y; Ramsay RG; Gonda TJ
Nucleic Acids Res; 2012 Jul; 40(13):5988-6000. PubMed ID: 22492511
[TBL] [Abstract][Full Text] [Related]
13. Variant estrogen receptor-alpha messenger RNA expression in hormone-independent human breast cancer cells.
Coutts AS; Leygue E; Murphy LC
J Mol Endocrinol; 1999 Dec; 23(3):325-36. PubMed ID: 10601978
[TBL] [Abstract][Full Text] [Related]
14. MYB suppresses differentiation and apoptosis of human breast cancer cells.
Drabsch Y; Robert RG; Gonda TJ
Breast Cancer Res; 2010; 12(4):R55. PubMed ID: 20659323
[TBL] [Abstract][Full Text] [Related]
15. Involvement of MyoD and c-myb in regulation of basal and estrogen-induced transcription activity of the BRCA1 gene.
Jin W; Liu Y; Chen L; Zhu H; Di GH; Ling H; Wu J; Shao ZM
Breast Cancer Res Treat; 2011 Feb; 125(3):699-713. PubMed ID: 20364308
[TBL] [Abstract][Full Text] [Related]
16. Estrogen receptor expression and function in long-term estrogen-deprived human breast cancer cells.
Jeng MH; Shupnik MA; Bender TP; Westin EH; Bandyopadhyay D; Kumar R; Masamura S; Santen RJ
Endocrinology; 1998 Oct; 139(10):4164-74. PubMed ID: 9751496
[TBL] [Abstract][Full Text] [Related]
17. Regulation of prothymosin alpha gene expression by estrogen in estrogen receptor-containing breast cancer cells via upstream half-palindromic estrogen response element motifs.
Martini PG; Katzenellenbogen BS
Endocrinology; 2001 Aug; 142(8):3493-501. PubMed ID: 11459795
[TBL] [Abstract][Full Text] [Related]
18. Estrogen regulation of vascular endothelial growth factor gene expression in ZR-75 breast cancer cells through interaction of estrogen receptor alpha and SP proteins.
Stoner M; Wormke M; Saville B; Samudio I; Qin C; Abdelrahim M; Safe S
Oncogene; 2004 Feb; 23(5):1052-63. PubMed ID: 14647449
[TBL] [Abstract][Full Text] [Related]
19. Microsatellite deletions in the c-myb transcriptional attenuator region associated with over-expression in colon tumour cell lines.
Thompson MA; Flegg R; Westin EH; Ramsay RG
Oncogene; 1997 Apr; 14(14):1715-23. PubMed ID: 9135073
[TBL] [Abstract][Full Text] [Related]
20. Estrogen-related receptor alpha1 transcriptional activities are regulated in part via the ErbB2/HER2 signaling pathway.
Ariazi EA; Kraus RJ; Farrell ML; Jordan VC; Mertz JE
Mol Cancer Res; 2007 Jan; 5(1):71-85. PubMed ID: 17259347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
